To read the entire report visit: www.microstockprofit.com/ads/KERX See what investors are saying about KERX at penny stock forum MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com …
I read this article and found it very interesting, thought it might be interesting for you. The article is called Keryx
Aurixya should be well revived by the nephrology community. "KERX's stock weakness on Friday was due to investor disappointment in January IMS scripts. However, historical data indicates that Aurixya scripts are in line with other …
Elements of this story were generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KERX at https://www.zacks.com/ap/KERX
Until the bill was introduced, Kasimov had been assuming that Keryx Biopharmaceuticals (NASDAQ:KERX) would have to make a roughly 33% gross-to-net discount once it became part of the ESRD bundle ... saw its stock price shoot up …
The stock’s market capitalization is 741.91M, it has a 52-week low of 4.03 and a 52-week high of 7.80. The share price of the company (KERX) was up +5.23%, with a high of 6.93 during the day and the volume of Keryx Biopharmaceuticals, …
Access a Zacks stock report on KERX at https://www.zacks.com/ap/KERX Never miss a local story. Sign up today for unlimited digital access to our website, apps, the digital newspaper and more.